论文部分内容阅读
目的 :观察复方卡尼汀注射液治疗病毒性肝炎的疗效。方法 :对照组 30例 ,男性 2 4例 ,女性 6例 ,年龄 ( 41±s 11)a ,常规保肝治疗 (菌栀黄 2 0mL ,iv ,gtt ,qd ,维生素C 2 .0g及维生素B60 .2g ,iv ,gtt ,qd等 ) ,疗程 4wk。治疗组 30例 ,男性2 4例 ,女性 6例 ,年龄 ( 45± 10 )a ,常规保肝治疗加用复方卡尼汀注射液 2支 ,iv ,gtt ,qd ,疗程 4wk。结果 :2组临床疗效比较差别有显著意义 (P<0 .0 5 ) ;2组丙氨酸转氨酶 (ALT)治疗前后比较差别均有显著意义 (P <0 .0 5 ) ,血清总胆红素 (TB)治疗前后比较 ,治疗组差别有显著意义 (P <0 .0 5 ) ,对照组差别无显著意义 (P >0 .0 5 ) ;治疗后 2组组间比较ALT差别无显著意义 (P >0 .0 5 ) ,TB差别有非常显著意义 (P <0 .0 1)。 2组均无明显副作用。结论 :复方卡尼汀注射液是一种有效安全的保肝药 ,尤以降低TB作用更佳
Objective: To observe the efficacy of compound carnitine injection in the treatment of viral hepatitis. Methods: The control group of 30 patients, 24 males and 6 females, age (41 ± s 11) a, conventional liver protection treatment (Zhizhi Huang 20mL, iv, gtt, qd, vitamin C 2 .0g and vitamin B60 .2g, iv, gtt, qd, etc.), treatment 4wk. Treatment group, 30 cases, 24 males and 6 females, age (45 ± 10) a, conventional liver protection plus compound carnitine injection 2, iv, gtt, qd, treatment 4wk. Results: There was significant difference between the two groups in the clinical curative effect (P <0.05). There was significant difference between the two groups before and after treatment of ALT (P <0.05), the total serum bilirubin (TB) before and after treatment, the difference between the treatment group was significant (P <0. 05), the control group was no significant difference (P> 0.05); after treatment, there was no significant difference between the two groups (P> 0.05), TB difference has a very significant (P <0. 01). There were no obvious side effects in both groups. Conclusion: Compound carnitine injection is an effective and safe hepatoprotective drugs, especially to reduce the role of TB better